What are gallstones?

The gallbladder is a small, pear-shaped organ tucked beneath the liver on the upper right side of the abdomen. Its job is to store bile — a yellow-green digestive fluid made by the liver — and release it into the small intestine after meals to help break down fats.

Gallstones are hard, solid deposits that form inside the gallbladder when the balance of substances in bile goes wrong. They range in size from a grain of sand to a golf ball, and a person can have one or several hundred at the same time.

Two main types

Around 80% of gallstones are cholesterol stones — formed when bile contains too much cholesterol relative to bile salts and lecithin, causing cholesterol to crystallise and clump together. The remaining 20% are pigment stones — smaller, darker deposits made mainly of bilirubin (a product of red blood cell breakdown), and associated with conditions such as liver cirrhosis (scarring of the liver) and haemolytic anaemia (a blood disorder where red cells break down too quickly).

Who gets them?

Gallstones are one of the most common digestive conditions in the UK. They are significantly more common in women than men, and risk increases with age. Medical students have long used the "5 Fs" as a quick-recall memory aid for the classic risk profile: Female, Forty, Fertile, Fat, and Fair. While no mnemonic captures the full picture, these factors do reflect real biological risk: oestrogen (a female sex hormone) raises cholesterol levels in bile and slows gallbladder emptying; pregnancy amplifies both effects; and excess body weight increases cholesterol output in bile.

Other important risk factors include a family history of gallstones, rapid weight loss, long-term fasting, and certain medications including HRT (hormone replacement therapy) and some contraceptive pills.

Most gallstones cause no symptoms

The majority of people with gallstones — around 80%1 — never experience any symptoms at all. These are called "silent" or asymptomatic gallstones, often discovered incidentally during an ultrasound or scan done for another reason. For most of these people, no treatment is needed.

The problems begin when a gallstone moves out of the gallbladder and gets wedged in one of the bile ducts — the small tubes connecting the gallbladder to the liver, small intestine, and pancreas. This triggers a cascade of possible complications depending on which duct is blocked and for how long.

80%
of people with gallstones never develop symptoms1

What happens when they do cause symptoms

When a gallstone temporarily blocks the cystic duct (the tube leading out of the gallbladder), it causes biliary colic — a severe, cramping pain in the upper right abdomen or the centre of the abdomen, often radiating to the right shoulder or back. The pain typically comes on suddenly after a fatty meal, lasts 30 minutes to several hours, and then subsides as the stone moves back or passes through. Despite the word "colic", the pain is usually constant during the episode rather than coming in waves.

If the blockage persists, the gallbladder becomes inflamed — a condition called acute cholecystitis (infection and swelling of the gallbladder). This produces more prolonged pain with fever, nausea, and tenderness on pressing the upper right abdomen. Gallstones can also travel into the common bile duct (the main tube draining bile from the liver) — called choledocholithiasis — causing jaundice (yellowing of the skin and whites of the eyes), or into the pancreatic duct, triggering gallstone pancreatitis (inflammation of the pancreas).

📖 Key Terms
Bile
A yellow-green digestive fluid made by the liver and stored in the gallbladder; released after meals to help digest fats.
Biliary colic
Severe, cramping upper abdominal pain caused by a gallstone temporarily blocking the cystic duct; typically lasting 30 minutes to several hours.
Cholecystectomy
Surgical removal of the gallbladder; most commonly performed as keyhole (laparoscopic) surgery under general anaesthetic.
Acute cholecystitis
Inflammation and infection of the gallbladder, usually caused by a gallstone blocking the cystic duct; causes persistent pain, fever, and tenderness.
Cholelithiasis
The medical term for the presence of gallstones inside the gallbladder.
Choledocholithiasis
Gallstones that have passed into the common bile duct (the main tube draining bile from the liver); can cause jaundice and cholangitis.
ERCP
Endoscopic Retrograde Cholangiopancreatography — a procedure combining a flexible camera (endoscope) with X-ray imaging to examine and treat problems in the bile and pancreatic ducts.
Gallstone pancreatitis
Inflammation of the pancreas triggered when a gallstone blocks the shared channel through which bile and pancreatic juices drain into the small intestine.
Cholangitis
Infection and inflammation of the bile ducts, usually caused by a blocked common bile duct; a potentially serious complication requiring urgent treatment.
Jaundice
Yellowing of the skin and whites of the eyes, caused by a build-up of bilirubin when bile cannot flow normally; a sign that the bile duct may be blocked.

Why does it matter?

15–20%
of UK adults have gallstones
One of the most prevalent digestive conditions in the country — and around 66,660 cholecystectomies (gallbladder removals) are performed in the UK every year.2
80%
remain silent throughout life
The majority of people with gallstones never develop symptoms and never need treatment — they are often found incidentally on a scan done for something else.1
7.6%
prevalence in women vs 5.4% in men
A 2024 meta-analysis of over 32 million people confirmed the female predominance globally3 — driven by oestrogen's effects on bile composition and gallbladder motility (how well the gallbladder contracts to empty).
22%
become symptomatic within 10 years
A cohort study of 22,257 patients found 10% developed symptoms within 5 years and 22% within 10 years — rising to 33% by 15 years.5 The longer stones remain silent, the less likely they are to cause problems.

The scale of gallstone disease makes it a significant public health issue — not because most cases are dangerous, but because the minority that do become symptomatic can escalate quickly. Gallstone pancreatitis is one of the leading causes of acute pancreatitis (sudden inflammation of the pancreas) in the UK, and cholangitis (bile duct infection) carries a meaningful mortality risk when not recognised and treated promptly.

Understanding the distinction between silent and symptomatic gallstones — and the factors that determine who crosses that line — is what this article is about. Most people with gallstones never need surgery. For those who do, the evidence now provides a clearer picture of when and why.

What your doctor might do

When gallstones are suspected — whether due to symptoms or as an incidental finding — assessment in UK practice typically follows a structured pathway.

🗣️
History and examination
The clinical history focuses on the character, location, and timing of any pain; associated features such as fever, jaundice (yellowing of the skin), or dark urine; and risk factors including BMI (body mass index), parity (number of pregnancies), family history, and relevant medications. On examination, Murphy's sign — tenderness and a pause in breathing when pressure is applied below the right rib cage during deep inspiration — is a classic indicator of acute cholecystitis. The 5 Fs risk profile (Female, Forty, Fertile, Fat, Fair) is a well-established clinical heuristic, though gallstones can and do occur outside this profile.
🩸
Blood tests
A standard assessment includes a full blood count (FBC), liver function tests (LFTs — measuring bilirubin, ALT, AST, ALP, and albumin), CRP (C-reactive protein — a marker of inflammation), and serum amylase or lipase (enzymes elevated in pancreatitis — inflammation of the pancreas). Raised bilirubin or ALP (alkaline phosphatase — an enzyme elevated when bile flow is obstructed) suggests a stone in the common bile duct. Elevated amylase points to pancreatic involvement.
🔊
Ultrasound — first-line imaging
Abdominal ultrasound is the primary investigation for suspected gallstones. It is non-invasive, involves no radiation, and detects gallbladder stones with high accuracy. It can also identify gallbladder wall thickening and pericholecystic fluid (fluid around the gallbladder) consistent with cholecystitis, and assess for bile duct dilation (widening of the bile duct, suggesting blockage). It is less reliable for visualising small stones within the common bile duct itself.
🧲
MRCP for suspected bile duct stones
If blood tests or ultrasound suggest stones in the common bile duct, MRCP (Magnetic Resonance Cholangiopancreatography — an MRI scan that creates detailed images of the bile and pancreatic ducts) provides a high-resolution, non-invasive view. It has replaced diagnostic ERCP for most patients, as ERCP (Endoscopic Retrograde Cholangiopancreatography) carries procedural risks and is now reserved primarily for treatment rather than diagnosis.
⏸️
Watchful waiting for asymptomatic gallstones
NICE guideline CG1884 recommends reassurance and no treatment for asymptomatic gallstones found in an otherwise normal gallbladder and biliary tree. The evidence supports this approach: the majority of people with silent gallstones will never develop complications. In UK practice, this means the incidental finding of gallstones on a scan is explained to the patient, who is advised about symptoms to watch for, and no surgical referral is made unless symptoms develop.
🔪
Laparoscopic cholecystectomy — keyhole gallbladder removal
NICE CG1884 recommends offering laparoscopic (keyhole) cholecystectomy to people with symptomatic gallstones — including those who have had biliary colic or acute cholecystitis. In UK practice this is typically performed as a day-case procedure under general anaesthetic using 3–4 small incisions. Recovery is usually 1–2 weeks. The gallbladder is not essential for normal digestion — the liver continues to produce bile, which drains directly into the small intestine.
🔬
ERCP for bile duct stones
Where stones are confirmed in the common bile duct (choledocholithiasis), ERCP is the standard treatment in UK practice. A flexible endoscope is passed through the mouth into the small intestine to the bile duct opening, the opening is widened (sphincterotomy — cutting the valve at the end of the bile duct), and stones are removed using a balloon or basket. This is typically performed before or at the time of cholecystectomy.
⚠️ Clinically time-sensitive features
  • Charcot's triad — right upper abdominal pain + fever + jaundice (yellowing of skin/eyes): suggests acute cholangitis (bile duct infection), clinically recognised as time-sensitive — 111 and urgent GP services exist for this.
  • Reynold's pentad — Charcot's triad plus low blood pressure and confusion: suggests severe cholangitis with septic shock — 999 exists for this.
  • Severe, persistent abdominal pain with vomiting that is not settling may indicate acute pancreatitis or cholecystitis — both clinically recognised as requiring hospital assessment.

What the research shows

Global prevalence of gallstones: a systematic review and meta-analysis
Meta-Analysis
Clinical Gastroenterology and Hepatology · 2024 · DOI: 10.1016/j.cgh.2024.01.051
7.6%
gallstone prevalence in women globally — versus 5.4% in men (32.6 million participants)
This large meta-analysis pooled data from 115 studies involving over 32.6 million participants to produce the most comprehensive global picture of gallstone prevalence to date. The overall pooled prevalence was 6.1% (95% CI — the range within which the true value most likely falls — 5.6–6.5%). When restricted to imaging-based detection (ultrasound or CT), the figure rose to 6.7% — reflecting that questionnaire-based studies likely under-detect asymptomatic cases. In Europe and the UK specifically, prevalence is higher, estimated at 15–20% of the general adult population — consistent with the rates seen in UK surgical practice.2 The study confirmed women are more affected than men across all regions, with a pooled prevalence of 7.6% in females versus 5.4% in males — a pattern attributed primarily to the effects of oestrogen (a female sex hormone) on bile composition and gallbladder emptying. Prevalence increased with age across all subgroups.
Ke H et al. Clin Gastroenterol Hepatol. 2024. DOI: 10.1016/j.cgh.2024.01.051
C-GALL RCT — surgery versus watchful waiting for symptomatic gallstones
UK RCT
Health Technology Assessment (NIHR) · 2024 · DOI: 10.3310/MNBY3104 · PubMed: 38943314
~50%
of those assigned to watchful waiting crossed over to surgery within 2 years
The C-GALL trial was a UK-based randomised controlled trial comparing laparoscopic cholecystectomy with conservative (watchful waiting) management in adults with uncomplicated symptomatic gallstone disease — those who had experienced biliary colic or acute cholecystitis but without serious complications. Adults suitable for surgery were randomised to either immediate cholecystectomy or observation, with follow-up of up to 24 months. The primary outcome was quality of life (QoL — overall wellbeing and physical function) measured using the SF-36 bodily pain domain (a validated patient questionnaire score).
The headline finding was that there was no significant difference in overall quality of life or bodily pain scores between the two groups at 24 months. However, condition-specific quality of life — how much the gallstone disease affected daily life — favoured surgery at 24 months (mean difference — MD — 9.0, 95% CI 4.1 to 14.0, p<0.001). People in the surgery group reported fewer ongoing problems related to their gallstone disease. From a cost perspective, conservative management was less costly over 24 months (mean difference −£1,033), though the incremental cost-effectiveness ratio (ICER — how much extra it costs to gain one quality-adjusted life-year) of £55,235 was above the standard NHS threshold of £20,000–£30,000 per QALY (quality-adjusted life-year — one year of life in perfect health). Notably, around half of people in the conservative management group went on to have surgery within 2 years, either due to worsening symptoms or complications.
Innes K, Ahmed I et al. Health Technol Assess. 2024;28(26):1–151. DOI: 10.3310/MNBY3104
NICE guideline CG188 — gallstone disease: diagnosis and management
NICE Guideline
National Institute for Health and Care Excellence · Published 2014, last reviewed 2018, confirmed current 2025
1 week
NICE target for cholecystectomy in acute cholecystitis — to reduce risk of complications during waiting period
NICE CG188 is the primary clinical framework used in England and Wales for gallstone management. Its key recommendations reflect the prevailing evidence: asymptomatic gallstones found in a normal gallbladder and biliary tree should not be treated — patients are simply reassured that no intervention is needed unless symptoms develop. For symptomatic gallstones, laparoscopic cholecystectomy is the recommended treatment. For acute cholecystitis, the guideline identifies early surgery (within 1 week of diagnosis) as a key priority for implementation — earlier cholecystectomy reduces the risk of recurrent episodes during a prolonged waiting period. Where common bile duct stones are confirmed, ERCP before or at the time of cholecystectomy is recommended to clear the duct. NICE also advises that following successful treatment, people do not need to restrict their diet — fatty foods only trigger symptoms when stones are present and blocking ducts.
🔑 Putting it all together

Gallstones are extremely common — affecting roughly 1 in 7 UK adults — but the majority cause no problems and require no treatment. The key distinction is between silent (asymptomatic) gallstones, where current evidence and NICE guidance support watchful waiting, and symptomatic gallstones, where laparoscopic cholecystectomy (keyhole gallbladder removal) remains the standard treatment in the UK.

The C-GALL trial — the best UK evidence to date — confirms that for uncomplicated symptomatic gallstones, surgery produces better condition-specific quality of life outcomes than watchful waiting over two years, even if the difference in overall pain scores is modest. Around half of people who choose watchful waiting will end up having surgery anyway. Understanding this helps people weigh up whether to proceed with surgery or wait.

The serious complications — acute cholecystitis, bile duct obstruction, gallstone pancreatitis, and cholangitis — are clinically time-sensitive and require prompt hospital assessment. If you or someone you know develops upper right abdominal pain with fever and jaundice, that combination is a recognised red flag. Everything else — the risk factors, the follow-up, the surgical decision — is a conversation for you to have with your GP or healthcare professional.

Most gallstones stay silent for life. Those that do speak up now have a well-evidenced treatment pathway — and knowing what to look for is the first step.

About the author — Dr Paul spent over twenty years as an NHS GP before retiring in 2019. helf.school exists to give every person access to clear, honest, evidence-based health education. Read more about Dr Paul →

References

1
Innes K, Ahmed I, Hudson J, Hernández R, Gillies K, Bruce R, et al. Laparoscopic cholecystectomy versus conservative management for adults with uncomplicated symptomatic gallstones: the C-GALL RCT. Health Technology Assessment. 2024;28(26):1–151.
2
Gana T, Narula HS. Management of asymptomatic cholelithiasis. Surgery (Oxford). 2023;41(7):436–439. ⚑ Full citation details to be verified before publication.
3
Ke H, Wang H, Ye M, et al. Global epidemiology of gallstones in the 21st century: a systematic review and meta-analysis. Clinical Gastroenterology and Hepatology. 2024. Published online February 2024.
4
National Institute for Health and Care Excellence. Gallstone disease: diagnosis and management. Clinical guideline CG188. Published October 2014; last reviewed August 2018; confirmed current 2025.
5
Morris-Stiff G, Sarvepalli S, Hu B, Gupta N, Lal P, Burke CA, et al. The natural history of asymptomatic gallstones: a longitudinal study and prediction model. Clinical Gastroenterology and Hepatology. 2023;21(2):319–327.e4.